Charles E. Cooley

Array ( [id] => 6550256 [patent_doc_number] => 20100233169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Methods for treating obesity using fibroblast growth factor-Like polypeptides' [patent_app_type] => utility [patent_app_number] => 12/721502 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30214 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233169.pdf [firstpage_image] =>[orig_patent_app_number] => 12721502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591454 [patent_doc_number] => 08349329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Antibodies that bind to PRO286' [patent_app_type] => utility [patent_app_number] => 12/717061 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 27 [patent_no_of_words] => 28026 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12717061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790956 [patent_doc_number] => 20120052512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE' [patent_app_type] => utility [patent_app_number] => 13/148030 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 21106 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052512.pdf [firstpage_image] =>[orig_patent_app_number] => 13148030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953801 [patent_doc_number] => 20110034374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Oxyntomodulin for Preventing or Treating Excess Weight' [patent_app_type] => utility [patent_app_number] => 12/696493 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 9210 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034374.pdf [firstpage_image] =>[orig_patent_app_number] => 12696493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500151 [patent_doc_number] => 20100215657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Methods and Compositions Using Klotho-FGF Fusion Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/696693 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 27039 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215657.pdf [firstpage_image] =>[orig_patent_app_number] => 12696693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982078 [patent_doc_number] => 08513192 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Stable growth hormone compounds resistant to proteolytic degradation' [patent_app_type] => utility [patent_app_number] => 13/144757 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17683 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13144757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104243 [patent_doc_number] => 08153770 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-04-10 [patent_title] => 'Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency' [patent_app_type] => utility [patent_app_number] => 12/684235 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7987 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153770.pdf [firstpage_image] =>[orig_patent_app_number] => 12684235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774775 [patent_doc_number] => 08119776 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-02-21 [patent_title] => 'Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency' [patent_app_type] => utility [patent_app_number] => 12/684209 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7982 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119776.pdf [firstpage_image] =>[orig_patent_app_number] => 12684209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104245 [patent_doc_number] => 08153771 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-04-10 [patent_title] => 'Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency' [patent_app_type] => utility [patent_app_number] => 12/684271 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7952 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153771.pdf [firstpage_image] =>[orig_patent_app_number] => 12684271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227213 [patent_doc_number] => 20120141424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'Materials and Methods for the Treatment of Hypertension' [patent_app_type] => utility [patent_app_number] => 13/143506 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17456 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13143506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940434 [patent_doc_number] => 20130190231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'PEPTIDE FOR SUPPRESSING AND TREATING OBESITY' [patent_app_type] => utility [patent_app_number] => 13/805156 [patent_app_country] => US [patent_app_date] => 2009-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 11881 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8266075 [patent_doc_number] => 20120165503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'OXYNTOMODULIN ANALOGS' [patent_app_type] => utility [patent_app_number] => 13/202524 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 40041 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8908973 [patent_doc_number] => 08481032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Lipocalin-2 antibodies for methods of treatment' [patent_app_type] => utility [patent_app_number] => 12/637097 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 13848 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12637097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656434 [patent_doc_number] => 20110305703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'ISOLATED VEGF-C AND VEGF-D PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/133559 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 27805 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305703.pdf [firstpage_image] =>[orig_patent_app_number] => 13133559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490058 [patent_doc_number] => 20120289465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'USE OF INHALABLE POWDER FORMULATION COMPRISING GROWTH HORMONE FOR PREVENTING OR TREATING NMDA RECEPTOR HYPOFUNCTION-RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/511451 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7124 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944046 [patent_doc_number] => 20110104666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'INSULIN RESISTANCE MARKER' [patent_app_type] => utility [patent_app_number] => 12/610977 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14167 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104666.pdf [firstpage_image] =>[orig_patent_app_number] => 12610977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328219 [patent_doc_number] => 08236312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'VEGF-specific human antibody' [patent_app_type] => utility [patent_app_number] => 12/580959 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 17372 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12580959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6614426 [patent_doc_number] => 20100099615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'PANCREATIC REGENERATING PROTEIN I IN CHRONIC PANCREATITIS AND AGING IMPLICATIONS FOR NEW THERAPEUTIC APPROACHES TO DIABETES' [patent_app_type] => utility [patent_app_number] => 12/579722 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9119 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099615.pdf [firstpage_image] =>[orig_patent_app_number] => 12579722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007859 [patent_doc_number] => 20110059890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'EXPRESSION VECTORS AND CELL LINES EXPRESSING VASCULAR ENDOTHELIAL GROWTH FACTOR D, AND METHOD OF TREATING MELANOMAS' [patent_app_type] => utility [patent_app_number] => 12/577496 [patent_app_country] => US [patent_app_date] => 2009-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11588 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059890.pdf [firstpage_image] =>[orig_patent_app_number] => 12577496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10554816 [patent_doc_number] => 09279013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-08 [patent_title] => 'FGF-21 mutants comprising polyethylene glycol and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/123205 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26534 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13123205 [rel_patent_id] =>[rel_patent_doc_number] =>)